Form 4: Elanco Director Scots-Knight Reports Stock Unit Grants
Insider Transaction Report
Denise Scots-Knight, a Director at Elanco Animal Health Inc., reported the acquisition of deferred stock units and restricted stock units on May 21, 2026.
Summary
- Denise Scots-Knight, a Director at Elanco Animal Health Inc. (ELAN), acquired equity awards on May 21, 2026.
- The awards include 4,678 deferred stock units and 12,196 restricted stock units.
- These grants are described as pro-rated annual equity awards for non-employee directors.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity grants to a director rather than significant financial performance or strategic shifts.
Positives
- Director Denise Scots-Knight received annual equity awards, indicating continued incentive and alignment with the company's performance.
- The grants of deferred stock units and restricted stock units suggest a commitment to retaining and rewarding key leadership.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that the granting of equity awards to directors is a common practice in the animal health industry to align executive and board compensation with shareholder interests and long-term company performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Denise Scots-Knight granted power of attorney to specific individuals to execute SEC filings on her behalf. | 05/21/2026 | Standard administrative procedure to ensure timely and accurate filing of required disclosures. |
Stakeholder Impact
- Shareholders: The grants reinforce director alignment with shareholder interests through equity ownership.
- Employees: Indirectly, as director compensation is part of overall corporate governance and operational costs.
- Management: Demonstrates standard compensation practices for non-employee directors.
Key Dates
| Date | Description |
|---|---|
| 05/21/2026 | Earliest transaction date and date of grant for stock units. |
| 05/26/2026 | Date of signature for the filing. |
Keywords
Elanco Animal Health, ELAN, Form 4, SEC Filing, Director, Equity Award, Stock Units, Deferred Stock Units, Restricted Stock Units, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.